Authors:
KOMOROWSKI J
JANKIEWICZ J
ROBAK T
BLASINSKAMORAWIEC M
STEPIEN H
Citation: J. Komorowski et al., CYTOKINES SERUM LEVELS AS THE MARKERS OF THYROID ACTIVATION IN GRAVES-DISEASE, Immunology letters, 60(2-3), 1998, pp. 143-148
Citation: M. Blasinskamorawiec et al., CORRELATION OF SEVERAL CYTOKINES AND THEIR SOLUBLE RECEPTORS WITH CLINICAL, HEMATOLOGICAL AND IMMUNOLOGICAL PARAMETERS IN UNTREATED PATIENTS WITH B-CELL LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 128-128
Authors:
BLASINSKAMORAWIEC M
ROBAK T
KRYKOWSKI E
HELLMANN A
URBANSKARYS H
Citation: M. Blasinskamorawiec et al., HAIRY-CELL LEUKEMIA-VARIANT TREATED WITH 2-CHLORODEOXYADENOSINE - A REPORT OF 3 CASES, Leukemia & lymphoma, 25(3-4), 1997, pp. 381-385
Authors:
ROBAK T
BLASINSKAMORAWIEC M
BLONSKI JZ
KRYKOWSKI E
KOMARNICKI M
TREPINSKA E
KAZMIERCZUK M
HANSZ J
DMOSZYNSKA A
ROLINSKI J
KONOPKA L
SKOTNICKI AB
NOWAK WS
KOTLAREKHAUS S
ZDZIARSKA B
URASINSKI I
Citation: T. Robak et al., THE EFFECT OF 2-H INFUSION OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) WITH PREDNISONE IN PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, European journal of cancer, 33(14), 1997, pp. 2347-2351
Authors:
ROBAK T
BLASINSKAMORAWIEC M
KRYKOWSKI E
HELLMANN A
LEWANDOWSKI K
DMOSZYNSKA A
ADAMCZYKCIOCH M
KAZIMIERCZAK M
TREPINSKA E
DWILEWICZTROJACZEK M
KURATOWSKA Z
SKOTNICKI AB
NOWAK WS
ZDZIARSKA B
URASINSKI I
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (CLADRIBINE)-RELATED EOSINOPHILIA IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES, European journal of haematology, 59(4), 1997, pp. 216-220
Authors:
ROBAK T
BLASINSKAMORAWIEC M
KRYKOWSKI E
HELLMANN A
KONOPKA L
Citation: T. Robak et al., AUTOIMMUNE HEMOLYTIC-ANEMIA IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA TREATED WITH 2-CHLORODEOXYADENOSINE (CLADRIBINE), European journal of haematology, 58(2), 1997, pp. 109-113
Authors:
ROBAK T
SYSAJEDRZEJOWSKA A
ROBAK E
DABKOWSKI J
BLASINSKAMORAWIEC M
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (CLADRIBINE) INDUCED ALLERGIC CUTANEOUS REACTIONS WITH EOSINOPHILIA IN A PATIENT WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of medicine, 28(3-4), 1997, pp. 199-209
Authors:
ROBAK T
BLASINSKAMORAWIEC M
BLONSKI JZ
KRYKOWSKI E
DMOSZYNSKA A
SKOTNICKI AB
KONOPKA L
HELLMANN A
KURATOWSKA Z
URASINSKI I
KOTLAREKHAUS S
MAJ S
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (2-CDA) AND PREDNISONE(P) VERSUS CHLORAMBUCIL (CHL) AND PREDNISONE AS A FIRST LINE THERAPY IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 2361-2361
Authors:
ROBAK T
BLASINSKAMORAWIEC M
KRYKOWSKI E
HANSZ J
KOMARNICKI M
KAZIMIERCZAK M
KONOPKA L
MAJ S
HELLMANN A
ZAUCHA JM
URASINSKI L
ZDZIARSKA B
KOTLAREKHAUS S
USNARSKAZUBKIEWICZ L
KURATOWSKA Z
DWILEWICZTROJACZEK J
HOLOWIECKI J
KRAWCZYKKULIS M
GRIEB P
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (2-CDA) IN 2-HOUR VERSUS 24-HOUR INTRAVENOUS-INFUSION IN THE TREATMENT OF PATIENTS WITH HAIRY-CELL LEUKEMIA, Leukemia & lymphoma, 22(1-2), 1996, pp. 107-111